ONO-1714
ONO-1714 is an orally active nitric oxide synthase inhibitor. ONO-1714 attenuates endotoxin-induced acute lung injury, reduces intestinal ischemia–reperfusion injury, represses biliary carcinogenesis.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 214479-33-1
- Formule: C7H12Cl2N2
- Masse moléculaire:195.09
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Activité biologique
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| Peritoneal macrophage cell | IC50 |
0.82 μM
Compound: 6, ONO-1714
|
Inhibition of LPS/INFgamma-induced nitric oxide production in CD-1 mouse peritoneal macrophages after 48 hrs by Griess reaction
Inhibition of LPS/INFgamma-induced nitric oxide production in CD-1 mouse peritoneal macrophages after 48 hrs by Griess reaction
|
[PMID: 22703704] |
Chemical Information
-
CAS No. 214479-33-1
-
Masse moléculaire 195.09
-
Formule C7H12Cl2N2
-
SMILES
Cl[C@@H]1[C@@]2([H])[C@]1([H])N=C(C[C@@H]2C)N.Cl
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
[1]. Mishima T, et al. Chemopreventative effect of an inducible nitric oxide synthase inhibitor, ONO-1714, on inflammation-associated biliary carcinogenesis in hamsters. Carcinogenesis. 2009 Oct;30(10):1763-7. [Content Brief]
[2]. Naito Y, et al. A novel potent inhibitor of inducible nitric oxide inhibitor, ONO-1714, reduces intestinal ischemia-reperfusion injury in rats. Nitric Oxide. 2004 May;10(3):170-7. [Content Brief]
[3]. Mikawa K, et al. ONO-1714, a nitric oxide synthase inhibitor, attenuates endotoxin-induced acute lung injury in rabbits. Anesth Analg. 2003 Dec;97(6):1751-1755. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)